Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saiju Jacob

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|October 2, 2021
The Role of Plasma Exchange in the Treatment of Refractory Autoimmune Neurological Diseases: a Narrative ReviewSaiju Jacob, Gordon Mazibrada, Sarosh R Irani, et al.
Journal of Neuromuscular Diseases|February 20, 2025
Disease burden, healthcare resource utilisation, and treatment patterns in patients with newly diagnosed myasthenia gravis in England: A retrospective cohort studyKerina Bonar, Nada Boudiaf, Piotr Zaremba, et al.
BMC Research Notes|January 23, 2014
Detection of branch retinal artery occlusions in Susac's syndromeStavroula Boukouvala, Saiju Jacob, Mark Lane, et al.
Journal of Neurology|March 20, 2020
'Minimal symptom expression' in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumabJohn Vissing, Saiju Jacob, Kenji P Fujita, et al.
European Journal of Neurology|December 20, 2023
Refocusing generalized myasthenia gravis: Patient burden, disease profiles, and the role of evolving therapyFrancesco Saccà, Emmanuelle Salort-Campana, Saiju Jacob, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|August 10, 2019
Enlarged and Enhancing Optic Nerves in Advanced Glial Fibrillary Acidic Protein MeningoencephalomyelitisDaniel White, Susan P Mollan, Satheesh Ramalingam, et al.
Clinical Neurology and Neurosurgery|July 16, 2025
Autoimmune glial fibrillary acidic protein astrocytopathy - The benefit of early diagnosis and initiation of therapy: A case reportIkechukwu Chukwuocha, Shilpi Shukla, Smriti Bose, et al.
Therapeutic Advances in Neurological Disorders|April 18, 2024
A retrospective observational study on characteristics, treatment patterns, and healthcare resource use of patients with myasthenia gravis in EnglandJordy van Enkhuizen, Jean Binns, April Betts, et al.
BMJ Neurology Open|April 3, 2025
Epidemiology and 10-year clinical care of juvenile myasthenia gravis in England: a retrospective cohort studyAli Abbasi, Kerina Bonar, Piotr Zaremba, et al.
Experimental Neurology|February 14, 2012
Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defectsStuart Viegas, Leslie Jacobson, Patrick Waters, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|October 2, 2021
The Role of Plasma Exchange in the Treatment of Refractory Autoimmune Neurological Diseases: a Narrative ReviewSaiju Jacob, Gordon Mazibrada, Sarosh R Irani, et al.
Journal of Neuromuscular Diseases|February 20, 2025
Disease burden, healthcare resource utilisation, and treatment patterns in patients with newly diagnosed myasthenia gravis in England: A retrospective cohort studyKerina Bonar, Nada Boudiaf, Piotr Zaremba, et al.
BMC Research Notes|January 23, 2014
Detection of branch retinal artery occlusions in Susac's syndromeStavroula Boukouvala, Saiju Jacob, Mark Lane, et al.
Journal of Neurology|March 20, 2020
'Minimal symptom expression' in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumabJohn Vissing, Saiju Jacob, Kenji P Fujita, et al.
European Journal of Neurology|December 20, 2023
Refocusing generalized myasthenia gravis: Patient burden, disease profiles, and the role of evolving therapyFrancesco Saccà, Emmanuelle Salort-Campana, Saiju Jacob, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|August 10, 2019
Enlarged and Enhancing Optic Nerves in Advanced Glial Fibrillary Acidic Protein MeningoencephalomyelitisDaniel White, Susan P Mollan, Satheesh Ramalingam, et al.
Clinical Neurology and Neurosurgery|July 16, 2025
Autoimmune glial fibrillary acidic protein astrocytopathy - The benefit of early diagnosis and initiation of therapy: A case reportIkechukwu Chukwuocha, Shilpi Shukla, Smriti Bose, et al.
Therapeutic Advances in Neurological Disorders|April 18, 2024
A retrospective observational study on characteristics, treatment patterns, and healthcare resource use of patients with myasthenia gravis in EnglandJordy van Enkhuizen, Jean Binns, April Betts, et al.
BMJ Neurology Open|April 3, 2025
Epidemiology and 10-year clinical care of juvenile myasthenia gravis in England: a retrospective cohort studyAli Abbasi, Kerina Bonar, Piotr Zaremba, et al.
Experimental Neurology|February 14, 2012
Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defectsStuart Viegas, Leslie Jacobson, Patrick Waters, et al.
Pageof 8